ENHO and Insulin resistance: Additionally, Adropin can regulate the expression of the lipogenic genes in the liver and adipose tissue peroxisome proliferator-activated receptor-γ (regulator of lipogenesis); therefore, it may behave as a factor controlling glucose and lipid homeostasis, which protects against hepatosteatosis and insulin resistance [41].